Clinical presentation, biochemical, and haematological parameters and their association with outcome in patients with Ebola virus disease: an observational cohort study.
about
The 2014–2015 Ebola outbreak in West Africa: Hands OnClinical Features of and Risk Factors for Fatal Ebola Virus Disease, Moyamba District, Sierra Leone, December 2014-February 2015Diagnosis of Ebola Virus Disease: Past, Present, and FutureExperimental Treatment with Favipiravir for Ebola Virus Disease (the JIKI Trial): A Historically Controlled, Single-Arm Proof-of-Concept Trial in GuineaClinical, virological, and biological parameters associated with outcomes of Ebola virus infection in Macenta, GuineaStrengthening Health Systems While Responding to a Health Crisis: Lessons Learned by a Nongovernmental Organization During the Ebola Virus Disease Epidemic in Sierra LeoneInsights from clinical research completed during the west Africa Ebola virus disease epidemic.Heterogeneities in the case fatality ratio in the West African Ebola outbreak 2013–2016Successful Implementation of a Multicountry Clinical Surveillance and Data Collection System for Ebola Virus Disease in West Africa: Findings and Lessons Learned.Ebola exposure, illness experience, and Ebola antibody prevalence in international responders to the West African Ebola epidemic 2014-2016: A cross-sectional study.Therapeutic efficacy of the small molecule GS-5734 against Ebola virus in rhesus monkeys.A Randomized, Controlled Trial of ZMapp for Ebola Virus InfectionEbola response in Sierra Leone: The impact on childrenUse of cystourethroscopy to remove an indwelling double-J ureteral stent 6 years following simultaneous radical sigmoid colon cancer and partial bladder resection: A case report.Clinical features of suspected Ebola cases referred to the Moyamba ETC, Sierra Leone: challenges in the later stages of the 2014 outbreak.Predicting Ebola Severity: A Clinical Prioritization Score for Ebola Virus Disease.Predicting Ebola infection: A malaria-sensitive triage score for Ebola virus diseaseEbola Virus RNA Stability in Human Blood and Urine in West Africa's Environmental Conditions.Design and analysis considerations in the Ebola_Tx trial evaluating convalescent plasma in the treatment of Ebola virus disease in Guinea during the 2014-2015 outbreak.Clinical Management of Ebola Virus Disease in the United States and EuropeEbola Virus Disease in Children, Sierra Leone, 2014-2015.Analysis of Diagnostic Findings From the European Mobile Laboratory in Guéckédou, Guinea, March 2014 Through March 2015Complete Genome Sequence of an Ebola Virus Isolate Imported from Sierra Leone to Germany Determined by Circle Sequencing.Electrolyte and Metabolic Disturbances in Ebola Patients during a Clinical Trial, Guinea, 2015.Validation of a portable, deployable system for continuous vital sign monitoring using a multiparametric wearable sensor and personalised analytics in an Ebola treatment centreA comparison of host gene expression signatures associated with infection in vitro by the Makona and Ecran (Mayinga) variants of Ebola virus.Influence of Referral Pathway on Ebola Virus Disease Case-Fatality Rate and Effect of Survival Selection BiasThe natural history of acute Ebola Virus Disease among patients managed in five Ebola treatment units in West Africa: A retrospective cohort study.Clinical Laboratory Values as Early Indicators of Ebola Virus Infection in Nonhuman Primates.Ebola Virus Disease in Humans: Pathophysiology and Immunity.Emerging sexually transmitted viral infections: 1. Review of Ebola virus disease.Field Validation of the ReEBOV Antigen Rapid Test for Point-of-Care Diagnosis of Ebola Virus Infection.Empiric intravenous fluid and electrolyte therapy in patients with Ebola virus disease.Viral haemorrhagic fever in children.Ebolavirus: An Overview of Molecular and Clinical Pathogenesis.Apheresis for collection of Ebola convalescent plasma in Liberia.Dynamic Phosphorylation of VP30 Is Essential for Ebola Virus Life Cycle.Therapeutics Against Filovirus Infection.Ebola virus inactivation by detergents is annulled in serum.Lactobacillus plantarum BSGP201683 Isolated from Giant Panda Feces Attenuated Inflammation and Improved Gut Microflora in Mice Challenged with Enterotoxigenic Escherichia coli
P2860
Q24049114-77150782-1A8E-49F0-991A-162CFFB4EBF4Q28387286-6CAA6AC4-04ED-483E-9620-3104C53BDAA4Q28388534-64F59C10-39DF-4B24-B5AB-8FB0A3A20A31Q28550455-270ECAD2-398B-496A-AFE6-60B3B28B3CC5Q29247868-A7EAB415-072B-4065-92A4-BF80614FDCA8Q30151739-86754431-ED92-48B7-A3E1-CD44E7E867EAQ30234590-B83F6EC8-A7FC-4E79-B0E0-33534010C26AQ30251101-1D4615A3-34B7-43E0-9E8F-CF2BC0948A2AQ31133910-A7DDAEE2-1C92-4A1F-A251-4314A9BE4C6AQ33693686-152464B8-73C6-4A52-97B6-128038DE94B9Q34516555-3C7CCEFC-7388-4134-83C4-EDCCAA47EE67Q34542427-E49781E5-8D5A-4A9D-95BE-8C0140890135Q36017586-ADD203DD-AA2E-41F8-BCAC-58A0C42739DAQ36055166-C7202EAD-9484-4B44-955B-6449FC8D1E59Q36059371-3704C03B-3AE5-435F-B116-F96FBB18EB58Q36267392-F13DB6D8-CFFD-49C5-8E2C-8CFC10A4F1B1Q36288282-061D7011-5908-464C-8015-FB5B72E5EC97Q36525318-44928C9E-84C1-45B0-B7D0-9BE30D419C4CQ36536012-2CDAB6D4-441B-4638-9887-6F8349F73A50Q37149584-61DFA058-26D0-4A11-B62E-43A8790692F6Q37288197-D9DC125F-BE70-4AF1-8D20-C26AF564ACFCQ37310771-D839FF02-D9F2-4618-B8D0-5C07DB57A5AEQ37318877-103EA0A2-B9E1-4735-B882-9F4F87624748Q37535900-3CCC4955-E84D-4E96-BF9E-704FFC8E38EBQ37659642-444E6431-3B68-437F-95F3-BD4F19A19A82Q37667895-FB44A1A4-6BE2-4E2F-9922-1CFCDFAA64A5Q37722312-1E34AA5B-4F75-40FF-B277-921E6B4DD76FQ38655105-9F3C196E-E652-4EAD-8249-7674DE6DF89EQ38670721-9D1784D1-B9E4-472D-9F5D-2E26AC70F619Q38707770-443B343D-5204-4539-9616-7275A5FB8E50Q38841962-98764454-6057-4CAD-93DA-E7D6943A2D55Q38913439-3B2E7614-C8EE-4E7F-89F6-7BD315BDDC17Q39088320-9FA83009-1C5D-4FA8-8298-450D3440DD21Q39199369-89FA2DDE-F9C1-4A52-BD97-BAB619F97605Q40054554-AF336A23-188B-48AF-837A-7FCA57A70612Q40097718-1AC2A077-A4F7-4E16-AA58-CBBCC1B07181Q40115600-72CAAFF6-B432-4FCC-BC86-90B8F1B4A165Q40144389-905525E9-206F-4DAA-9482-8E59E19AC16DQ41927854-794CD4B3-1C5D-4A60-B72C-482136D4BDCFQ42368485-91C7BBAB-DE87-4B99-8C0B-72B99DD0078B
P2860
Clinical presentation, biochemical, and haematological parameters and their association with outcome in patients with Ebola virus disease: an observational cohort study.
description
2015 nî lūn-bûn
@nan
2015 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
Clinical presentation, biochem ...... an observational cohort study.
@ast
Clinical presentation, biochem ...... an observational cohort study.
@en
type
label
Clinical presentation, biochem ...... an observational cohort study.
@ast
Clinical presentation, biochem ...... an observational cohort study.
@en
prefLabel
Clinical presentation, biochem ...... an observational cohort study.
@ast
Clinical presentation, biochem ...... an observational cohort study.
@en
P2093
P50
P1476
Clinical presentation, biochem ...... an observational cohort study.
@en
P2093
Alpha Sheriff
Catherine Houlihan
Emmanuel Tamba
Fayia Tamba
Kongoneh Tamba
Rachael Cummings
Saidu Heisenberg-Mansaray
Shelagh Tobin
Sulaiman Conteh
Tim Brooks
P304
P356
10.1016/S1473-3099(15)00144-9
P577
2015-08-10T00:00:00Z